Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Central Nervous System Toxoplasmosis is an Under-Recognized Opportunistic infection in Uganda.

Journal of tropical medicine·2026
Same author

Thermal-chemical characterization of hydrochloric acid-treated rice husk-pine sawdust heterogeneous briquettes.

Scientific reports·2026
Same author

Cerebrospinal fluid transcriptional immune pathways linked to survival in HIV-associated tuberculous meningitis.

The Journal of infectious diseases·2026
Same author

Investigation of human leukocyte antigen alleles as risk factors for cryptococcal disease in Ugandan individuals with HIV.

Human immunology·2026
Same author

Change in plasma cryptococcal antigen titers in Uganda among outpatients with advanced HIV disease from 2017 to 2022 with rollout of national cryptococcal screening.

PloS one·2026
Same author

Pulmonary Aspergillosis Treated With Oral Amphotericin B (MAT2203) in a Patient With HIV-Related Cryptococcal Meningitis.

Clinical case reports·2026

Related Experiment Video

Updated: Jun 18, 2026

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals
09:27

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals

Published on: May 30, 2013

HIV-Associated Cryptococcal Meningitis: A Call for Action for New Treatment Options.

Samuel Okurut1, David B Meya1,2,3

  • 1Research Department, Infectious Diseases Institute, Makerere University, Kampala P. O. Box 22418, Uganda.

Therapeutics
|June 17, 2026
PubMed
Summary

Cryptococcal meningitis, a severe infection in advanced HIV disease patients, has a high 19% in-hospital death rate. Survival significantly drops from diagnosis to 10 weeks, highlighting the urgent need for better treatments.

Keywords:
antifungal therapyclinical trialscryptococcal meningitishuman immunodeficiency virusmortality improved regimensurvival

More Related Videos

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Related Experiment Videos

Last Updated: Jun 18, 2026

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals
09:27

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals

Published on: May 30, 2013

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Area of Science:

  • Infectious Diseases
  • HIV/AIDS Research
  • Mycology

Background:

  • Cryptococcal meningitis is a leading cause of meningitis in adults with advanced HIV.
  • Despite treatment advances, the in-hospital mortality rate remains high at 19%.

Purpose of the Study:

  • To analyze survival outcomes in cryptococcal meningitis clinical trials.
  • To identify challenges in treating this opportunistic infection in HIV patients.

Main Methods:

  • Review of aggregate clinical trial data for cryptococcal meningitis.
  • Analysis of survival endpoints at 2 weeks and 10 weeks post-treatment initiation.
  • Comparison of outcomes using the World Health Organization-recommended standard of care.

Main Results:

  • Survival decreased significantly from 88.5% at 2 weeks to 74% at 10 weeks (p = 0.001).
  • No statistically significant difference in survival was observed between trial randomization arms.
  • High mortality persists despite current treatment standards.

Conclusions:

  • Cryptococcal meningitis continues to pose a significant mortality risk in HIV patients.
  • Challenges include disease complications, treatment delays, comorbidities, and post-discharge deterioration.
  • There is a critical need for novel evidence-based therapies to improve patient outcomes.